Reuters logo
BRIEF-Cytori to expand Scleroderma focus to its broader hand therapy franchise
January 10, 2017 / 3:13 PM / a year ago

BRIEF-Cytori to expand Scleroderma focus to its broader hand therapy franchise

Jan 10 (Reuters) - Cytori Therapeutics Inc :

* Cytori to expand scleroderma focus to broader hand therapy franchise under the habeo cell therapy brand

* Anticipates unblinding of controlled phase 3 clinical trial in patients with scleroderma in mid-2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below